RecruitingNCT05203250

Longitudinal Registry Including Patients Treated With Heavy Particles

CNAO REgistry triAL - REGAL

Sponsor

CNAO National Center of Oncological Hadrontherapy

Enrollment

3,000 participants

Start Date

Jun 4, 2021

Study Type

OBSERVATIONAL

Conditions

Rare Disease Radiotherapy Side Effect Cancer Oncology Radiation Toxicity Radiation Exposure

Summary

The purpose of this registry is to collect retrospective and prospective standardized data of patients treated with particle therapy, either with protons or carbon ions, at the National Center for Oncological Hadrontherapy (CNAO) based in Pavia. By keeping track of the patients treated, it will allow the investigators to periodically analyze and evaluate data collected of daily clinical activity. This will help gathering more information on the results of particle therapy and will provide the basis for in depth evaluation of patients' outcome with respect to the delivered treatment.

Eligibility

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Heavy-ion therapy (hadrontherapy) for people with cancer, oncology, and other related conditions. The study is currently recruiting participants at 1 location.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

RADIATIONHeavy-ion therapy (hadrontherapy)

Only data available from routine clinical practice at the National Center for Oncological Hadrontherapy (CNAO), based Pavia, will be collected. Intervention is not assigned.